{"id":56972,"date":"2024-02-27T17:16:42","date_gmt":"2024-02-27T17:16:42","guid":{"rendered":"https:\/\/medsname.com\/ezedoc\/"},"modified":"2026-08-28T11:51:18","modified_gmt":"2026-08-28T11:51:18","slug":"ezedoc","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/ezedoc\/","title":{"rendered":"Ezedoc"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin: 0 0 8px 0; font-size: 16px; font-weight: bold;\">\u26a1 Quick Answer \u2014 What is Ezedoc?<\/h3>\n<p style=\"margin: 0;\"><strong>Ezedoc<\/strong> tartalmaz <strong>ezetimibe<\/strong> (10 mg), egy <strong>koleszterinfelsz\u00edv\u00f3d\u00e1s-g\u00e1tl\u00f3<\/strong> ami blokkolja az NPC1L1 transzportert a v\u00e9konyb\u00e9lben. Ez az <strong>go-to add-on therapy when a statin alone doesn\u2019t get LDL to target<\/strong>. On its own, ezetimibe lowers LDL-C by about 17\u201322%. Added to a statin, it produces an additional ~20\u201325% LDL reduction, totaling a 55\u201360% fall \u2014 equivalent to doubling the statin dose without the dose-related muscle or liver side effects. The <strong>IMPROVE-IT<\/strong> trial (18,144 patients post-ACS) proved that adding ezetimibe to simvastatin further reduces cardiovascular events. Dose: 10\u00a0mg once daily, any time, with or without food. Generally very well-tolerated \u2014 mild GI upset, occasional myalgia, rare transaminase elevation. Avoid in severe hepatic impairment.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Mit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Minden rendel\u00e9st fedez a <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\"><strong>\u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n<h3>Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n<p>Generikus gy\u00f3gyszereink WHO-GMP tan\u00fas\u00edtv\u00e1nnyal rendelkez\u0151 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, sima csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomag k\u00fcls\u0151 fel\u00fclet\u00e9n nem szerepel gy\u00f3gyszern\u00e9v. A k\u00e1rty\u00e1s fizet\u00e9seket szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl ir\u00e1ny\u00edtjuk (a sz\u00e1mlale\u00edr\u00f3k k\u00f6z\u00f6tt szerepel egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3 \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszern\u00e9v). Kriptovaluta \u00e9s SEPA banki \u00e1tutal\u00e1s is elfogadott. Minden rendel\u00e9st Reshipment Assurance Policy garanci\u00e1nk t\u00e1mogat.<\/p>\n<h2 class=\"wp-block-heading\">Mi az Ezedoc?<\/h2>\n<p>Az Ezedoc egy or\u00e1lis lipidcs\u00f6kkent\u0151 gy\u00f3gyszer, amely <strong>ezetimibe<\/strong> (10 mg) hat\u00f3anyagot tartalmaz, WHO-GMP tan\u00fas\u00edtv\u00e1nnyal rendelkez\u0151 gy\u00e1rt\u00f3 \u00e1ltal el\u0151\u00e1ll\u00edtva. 30, 60, 90 vagy 180 tablett\u00e1s csomagol\u00e1sban kaphat\u00f3. Az ezetimib az els\u0151 \u00e9s egyetlen gy\u00f3gyszer a <strong>koleszterinfelsz\u00edv\u00f3d\u00e1s-g\u00e1tl\u00f3<\/strong> oszt\u00e1lyb\u00f3l. Eredeti m\u00e1rka: <strong>Zetia \/ Ezetrol<\/strong> (Merck, 2002).<\/p>\n<p>Ezetimibe is a mainstay of second-line lipid management \u2014 the first choice when you need more LDL reduction than a tolerated statin dose provides, or when a patient cannot tolerate higher statin doses. It is also the most common partner in fixed-dose combinations (simvastatin\/ezetimibe = Inegy\/Vytorin; rosuvastatin\/ezetimibe = various).<\/p>\n<h2 class=\"wp-block-heading\">Mire haszn\u00e1lj\u00e1k az Ezedocot?<\/h2>\n<ul>\n<li><strong>Primer hiperkolesterin\u00e9mia<\/strong> \u2014 as add-on to a statin when LDL is not at goal on the maximum tolerated statin dose<\/li>\n<li><strong>Sztatin intolerancia<\/strong> \u2014 as monotherapy or with a very low statin dose when a full statin dose causes muscle or liver problems<\/li>\n<li><strong>Familialis hypercholesterinaemia<\/strong> (heterozygous and homozygous) \u2014 in combination with statin<\/li>\n<li><strong>M\u00e1sodlagos megel\u0151z\u00e9s akut coronari\u00e1s szindr\u00f3ma ut\u00e1n<\/strong> \u2014 add to statin to further reduce CV events (IMPROVE-IT trial)<\/li>\n<li><strong>Szitoszterol\u00e9mia<\/strong> \u2014 a rare genetic condition where ezetimibe is disease-modifying<\/li>\n<\/ul>\n<p>Ezetimibe is weak as a monotherapy (~17% LDL reduction) compared to a statin (~30\u201360%); it is most powerful as an add-on.<\/p>\n<h2 class=\"wp-block-heading\">Hogyan m\u0171k\u00f6dik az Ezedoc?<\/h2>\n<p>Az ezetimib szelekt\u00edven g\u00e1tolja a <strong>Niemann-Pick C1-Like 1 (NPC1L1) transzportert<\/strong> a b\u00e9lny\u00e1lkah\u00e1rtya enterocit\u00e1in a proxim\u00e1lis v\u00e9konyb\u00e9lben. Az NPC1L1 felel\u0151s a t\u00e1pl\u00e1l\u00e9kb\u00f3l \u00e9s az epeb\u0151l sz\u00e1rmaz\u00f3 koleszterin felsz\u00edv\u00e1s\u00e1\u00e9rt a b\u00e9l lumenb\u0151l az enterocit\u00e1ba.<\/p>\n<p>Az NPC1L1 blokkol\u00e1s\u00e1val:<\/p>\n<ul>\n<li><strong>A b\u00e9l koleszterinfelsz\u00edv\u00e1sa ~54%-kal cs\u00f6kken<\/strong><\/li>\n<li><strong>A m\u00e1j koleszterink\u00e9szlete cs\u00f6kken<\/strong> mivel kevesebb koleszterin \u00e9r el a m\u00e1jhoz<\/li>\n<li><strong>Az LDL-receptorok regul\u00e1ci\u00f3ja fokoz\u00f3dik<\/strong> on hepatocytes \u2014 the liver pulls more LDL out of the blood<\/li>\n<li><strong>Plasma LDL-C falls by 17\u201322%<\/strong> monoter\u00e1piak\u00e9nt; ak\u00e1r tov\u00e1bbi 25%-kal statin kombin\u00e1ci\u00f3 eset\u00e9n<\/li>\n<li>A HMG-CoA-redukt\u00e1z aktivit\u00e1sa (a statinok c\u00e9lpontja) v\u00e1ltozatlan marad<\/li>\n<\/ul>\n<p>Mivel az ezetimib \u00e9s a statinok <strong>kieg\u00e9sz\u00edt\u0151 hat\u00e1s\u00fa \u00fatvonalakon hatnak<\/strong> (absorption vs synthesis), their effects are additive. Statins reduce LDL synthesis; ezetimibe reduces LDL absorption\/input. Together they drop LDL more than either can alone, without adding to each other\u2019s side-effect profile.<\/p>\n<p>Eredm\u00e9nyadatok: az <strong>IMPROVE-IT vizsg\u00e1lat<\/strong> (2015) kimutatta, hogy ezetimib hozz\u00e1ad\u00e1sa szimvasztatinhoz ACS ut\u00e1ni betegekn\u00e9l 6,4%-kal cs\u00f6kkentette az \u00f6sszetett CV v\u00e9gpontot (NNT 50 7 \u00e9v alatt), meger\u0151s\u00edtve, hogy az LDL-cs\u00f6kken\u00e9s val\u00f3di esem\u00e9nycs\u00f6kken\u00e9shez vezet.<\/p>\n<h2 class=\"wp-block-heading\">Adagol\u00e1s \u00e9s alkalmaz\u00e1s<\/h2>\n<p><strong>Standard adag:<\/strong> 10\u00a0mg once daily at any time of day, with or without food.<\/p>\n<ul>\n<li>Fogyassza k\u00f6vetkezetesen ugyanabban az id\u0151pontban a betart\u00e1s \u00e9rdek\u00e9ben.<\/li>\n<li>Can be taken at the same time as a statin or spaced out \u2014 no timing interaction.<\/li>\n<li>Miss a dose \u2014 take it as soon as you remember unless close to the next; do not double up.<\/li>\n<li>Nem sz\u00fcks\u00e9ges d\u00f3zism\u00f3dos\u00edt\u00e1s veseel\u00e9gtelens\u00e9g vagy enyhe-m\u00e9rs\u00e9kelt m\u00e1jk\u00e1rosod\u00e1s eset\u00e9n.<\/li>\n<li>Monitor lipid panel and ALT at baseline and 6\u20138 weeks after starting. Check CK only if symptoms.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Mell\u00e9khat\u00e1sok<\/h2>\n<p>Az ezetimib az egyik legjobban toler\u00e1lt lipidszint-cs\u00f6kkent\u0151 gy\u00f3gyszer. A mell\u00e9khat\u00e1sok k\u00f6zel \u00e1llnak a placeb\u00f3hoz a vizsg\u00e1latokban.<\/p>\n<p><strong>Gyakori (&lt;5%):<\/strong><\/p>\n<ul>\n<li>Enyhe hasmen\u00e9s, flatulencia<\/li>\n<li>Fels\u0151 l\u00e9g\u00fati fert\u0151z\u00e9s, sinusitis<\/li>\n<li>F\u00e1radts\u00e1g<\/li>\n<li>\u00cdz\u00fcleti f\u00e1jdalom<\/li>\n<\/ul>\n<p><strong>Nem gyakori:<\/strong><\/p>\n<ul>\n<li>Transaminase elevation \u2014 usually small; more common when combined with a statin<\/li>\n<li>Muscle pain, myalgia, myopathy \u2014 rare; primarily when combined with statin<\/li>\n<li>T\u00fal\u00e9rz\u00e9kenys\u00e9g, angio\u00f6d\u00e9ma, ki\u00fct\u00e9s<\/li>\n<li>Pancreatitis \u2014 very rare<\/li>\n<li>Cholelithiasis \u2014 very rare<\/li>\n<li>Thrombocytopenia \u2014 very rare<\/li>\n<li>Rhabdomyolysis \u2014 exceedingly rare, almost always in combination with a statin<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sok<\/h2>\n<ul>\n<li><strong>Ciklosporin<\/strong> \u2014 significantly raises ezetimibe levels (and vice versa). Monitor cyclosporine levels; some guidance suggests avoiding.<\/li>\n<li><strong>\u2014 nincs k\u00e1ros PK k\u00f6lcs\u00f6nhat\u00e1s; ez a kombin\u00e1ci\u00f3 a ter\u00e1pi\u00e1s alap.<\/strong> (cholestyramine, colestipol) \u2014 reduce ezetimibe absorption; take ezetimibe at least 2 hours before or 4 hours after.<\/li>\n<li><strong>Varfarin<\/strong> \u2014 occasional INR change reported; monitor when starting.<\/li>\n<li><strong>Statinok<\/strong> \u2014 no adverse PK interaction; this combination is the therapeutic mainstay.<\/li>\n<li><strong>M\u00e9rs\u00e9kelt-s\u00falyos m\u00e1jk\u00e1rosod\u00e1s (statinnal kombin\u00e1lva)<\/strong> \u2014 fenofibrate\/ezetimibe combination is safe; gemfibrozil raises ezetimibe levels and is generally avoided.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Terhess\u00e9g (statinnal kombin\u00e1lva)<\/h2>\n<ul>\n<li>K\u00f6zepesen s\u00falyos vagy s\u00falyos m\u00e1jk\u00e1rosod\u00e1s (statinnal kombin\u00e1lva)<\/li>\n<li>Active liver disease or persistent transaminase elevation &gt; 3\u00d7 ULN<\/li>\n<li>Terhess\u00e9g (statinnel kombin\u00e1lva)<\/li>\n<li>Szoptat\u00e1s<\/li>\n<li>10 \u00e9v alatti gyermekek (nincs elegend\u0151 adat)<\/li>\n<li>Ismert ezetimib-\u00e9rz\u00e9kenys\u00e9g<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">T\u00e1rol\u00e1s<\/h2>\n<p>Store Ezedoc below 25\u00b0C in a dry place, in the original blister. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Gyakran Ism\u00e9telt K\u00e9rd\u00e9sek<\/h2>\n<h3 class=\"wp-block-heading\">Bevehetem az Ezedoc-ot sztatin helyett?<\/h3>\n<p>Usually no. As monotherapy, ezetimibe lowers LDL by only ~17% \u2014 much less than a statin (30\u201360%). It is appropriate as monotherapy only for patients who cannot tolerate any statin at any dose. For most people, the best lipid-lowering strategy is statin first, ezetimibe added if LDL is still above target.<\/p>\n<h3 class=\"wp-block-heading\">Hogyan hasonl\u00edt az Ezedoc a sztatin adag dupl\u00e1z\u00e1s\u00e1hoz?<\/h3>\n<p>Doubling a statin dose typically adds ~6% LDL reduction (the statin \u201crule of 6\u201d). Adding ezetimibe adds ~20\u201325% LDL reduction. <strong>Adding ezetimibe is 3\u20134\u00d7 more effective<\/strong> mint a sztatin dupl\u00e1z\u00e1sa, \u00e9s a d\u00f3zisf\u00fcgg\u0151 izomt\u00fcnetek n\u00f6veked\u00e9se n\u00e9lk\u00fcl. Ez\u00e9rt r\u00e9szes\u00edtik el\u0151nyben a modern ir\u00e1nyelvek a sztatin + ezetimib kombin\u00e1ci\u00f3t a sztatin maxim\u00e1lis adagj\u00e1nak n\u00f6vel\u00e9se helyett.<\/p>\n<h3 class=\"wp-block-heading\">Cs\u00f6kkenti az Ezedoc a sz\u00edvrohamok \u00e9s az agyv\u00e9rz\u00e9sek kock\u00e1zat\u00e1t?<\/h3>\n<p>Yes \u2014 the IMPROVE-IT trial (18,144 post-ACS patients) showed adding ezetimibe to simvastatin reduced the composite endpoint of CV death, MI, unstable angina, revascularisation, or stroke by 6.4% over 7 years. This is the landmark evidence that LDL reduction beyond statins alone still translates into real cardiovascular benefit.<\/p>\n<h3 class=\"wp-block-heading\">Mikor kell bevenni az Ezedoc-ot?<\/h3>\n<p>Any time of day is fine. Unlike simvastatin (evening preferred), ezetimibe timing is not dose-dependent \u2014 pick a time you will remember consistently. Many patients take it at the same time as their statin.<\/p>\n<h3 class=\"wp-block-heading\">Az Ezedoc izomf\u00e1jdalmat okoz, mint a sztatinok?<\/h3>\n<p>Ritk\u00e1n. Az ezetimib monoter\u00e1pia placebo-szint\u0171 izommel kapcsolatos mell\u00e9khat\u00e1sokat mutat. Ha sztatinnal kombin\u00e1lj\u00e1k, nem n\u00f6veli jelent\u0151sen a sztatinnal kapcsolatos izomt\u00fcneteket a sztatin \u00f6nmag\u00e1hoz k\u00e9pest.<\/p>\n<h3 class=\"wp-block-heading\">Hol lehet online megv\u00e1s\u00e1rolni az Ezedoc-ot?<\/h3>\n<p>Az Ezedoc-ot (10 mg) rendelheti a MedsBase-t\u0151l 30, 60, 90 vagy 180 tablett\u00e1s csomagol\u00e1sban. Vil\u00e1gszerte sz\u00e1ll\u00edtunk, diszkr\u00e9t csomagol\u00e1sban \u00e9s hiteles WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3i k\u00e9szletb\u0151l.<\/p>\n<h2 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 koleszterin-szint cs\u00f6kkent\u0151 gy\u00f3gyszerek<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/lipvas\/\">Lipvas \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/crestor\/\">Crestor \u2014 Rosuvastatin 5\/10\/20 mg (AstraZeneca)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/rosuline\/\">Rosuline \u2014 Rosuvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/atorvatin\/\">Atorvatin \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/pivasta\/\">Pivasta \u2014 Pitavastatin (interaction-clean)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/lipicard\/\">Lipicard \u2014 Fenofibrate (for triglycerides)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/high-cholesterol-treatments\/\"><strong>\u00d6sszes magas koleszterin-szint\u0171 gy\u00f3gyszer b\u00f6ng\u00e9sz\u00e9se<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background: #fff3f3; border-left: 4px solid #d9534f; padding: 16px 20px; margin: 24px 0; border-radius: 4px;\"><strong>\u2695 Medical Disclaimer.<\/strong> Ez az oldal csak t\u00e1j\u00e9koztat\u00f3 jelleg\u0171, \u00e9s nem helyettes\u00edti a kvalifik\u00e1lt eg\u00e9szs\u00e9g\u00fcgyi szakember \u00e1ltal ny\u00fajtott orvosi tan\u00e1csot. Magyar\u00e1zatlan izomf\u00e1jdalom, b\u0151r vagy szem s\u00e1rgul\u00e1sa, vagy s\u00falyos hasi f\u00e1jdalom eset\u00e9n azonnali orvosi \u00e9rt\u00e9kel\u00e9s sz\u00fcks\u00e9ges.<\/div>\n<h3 class=\"wp-block-heading\">Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n<p>Az Ezedoc-ot WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 sz\u00e1ll\u00edtja, teljes COA dokument\u00e1ci\u00f3val. Vil\u00e1gszerte sz\u00e1ll\u00edtunk egyszer\u0171, diszkr\u00e9t csomagol\u00e1sban, \u00e9s minden rendel\u00e9st fedez a <a href=\"\/hu\/medsbase-re-shipment-assurance-policy\/\">\u00dajrak\u00fcld\u00e9si Garancia<\/a>. Your statement descriptor when paying by card shows the regulated payment processor (a regulated card-payment processor), never \u201cMedsBase\u201d or any medication name.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k<\/h3>\n<p>Egy\u00e9b term\u00e9kek a <strong>Kr\u00f3nikus betegs\u00e9gek<\/strong> v\u00e1s\u00e1rl\u00f3k \u00e1ltal szint\u00e9n megtekintett term\u00e9kek:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/bencid\/\">Bencid<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/tiova-rotacaps\/\">Tiova Rotacaps<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/serobid-rotacaps\/\">Serobid Rotacaps<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/headset\/\">Headset<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/xafinact\/\">Xafinact<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Cs\u00f6kkenti a koleszterinszintet<br \/>\n\u2705 Cs\u00f6kkenti a sz\u00edvbetegs\u00e9g kock\u00e1zat\u00e1t<br \/>\n\u2705 Megel\u0151zi az \u00e9relmeszesed\u00e9st<br \/>\n\u2705 Orvos \u00e1ltal fel\u00edrt<br \/>\n\u2705 Sz\u00e1jon \u00e1t szedhet\u0151 gy\u00f3gyszer opci\u00f3<\/p>\n<p><strong>Ezedoc<\/strong> tartalmaz <strong>Ezetimibe<\/strong>.<\/p>","protected":false},"featured_media":56973,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3953],"product_tag":[4210,4211],"class_list":{"0":"post-56972","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-high-cholesterol-treatments","9":"product_tag-ezedoc","10":"product_tag-ezetimibe","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product\/56972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/comments?post=56972"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media\/56973"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media?parent=56972"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_brand?post=56972"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat?post=56972"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_tag?post=56972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}